BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23832865)

  • 1. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
    van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
    Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.
    van Duinen N; Steenvoorden D; Kema IP; Jansen JC; Vriends AH; Bayley JP; Smit JW; Romijn JA; Corssmit EP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):209-14. PubMed ID: 19897674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
    de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
    Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
    Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine-producing tumors.
    Pussard E; Chaouch A; Said T
    Clin Chem Lab Med; 2014 Mar; 52(3):437-44. PubMed ID: 24088613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma free metanephrines for diagnosis of neuroblastoma patients.
    Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
    Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas.
    van Hulsteijn LT; van Duinen N; Romijn JA; Smit JW; Corssmit EP
    Int J Biol Markers; 2012 Jul; 27(2):e160-3. PubMed ID: 22653742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
    Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine excess in patients with head and neck paragangliomas.
    Van Der Horst-Schrivers AN; Osinga TE; Kema IP; Van Der Laan BF; Dullaart RP
    Anticancer Res; 2010 Dec; 30(12):5153-8. PubMed ID: 21187504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.
    Osinga TE; Korpershoek E; de Krijger RR; Kerstens MN; Dullaart RP; Kema IP; van der Laan BF; van der Horst-Schrivers AN; Links TP
    Neuroendocrinology; 2015; 101(4):289-95. PubMed ID: 25677368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites.
    Peitzsch M; Pelzel D; Glöckner S; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Eisenhofer G
    Clin Chim Acta; 2013 Mar; 418():50-8. PubMed ID: 23313054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma.
    Gupta P; Khurana ML; Khadgawat R; Bal CS; Kumar G; Sharma SC; Tandon N
    Indian J Endocrinol Metab; 2015; 19(5):633-8. PubMed ID: 26425473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis.
    Woo HI; Yang JS; Oh HJ; Cho YY; Kim JH; Park HD; Lee SY
    Clin Biochem; 2016 May; 49(7-8):573-9. PubMed ID: 26779993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated urinary free and deconjugated catecholamines after consumption of a catecholamine-rich diet.
    de Jong WH; Post WJ; Kerstens MN; de Vries EG; Kema IP
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2851-5. PubMed ID: 20382681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.
    Smy L; Kushnir MM; Frank EL
    J Mass Spectrom Adv Clin Lab; 2021 Aug; 21():19-26. PubMed ID: 34820673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.